Hyperkalemia (HK) is a common complication in patients with HFrEF receiving guideline-directed medical therapy (GDMT), yet real-world data on its determinants, management, and prognostic impact are limited.
To describe the incidence and severity of HK, identify factors associated with its occurrence, chara...
M. Mantovani, N. Bonini, M. Vitolo et al.· European Heart Journal· 0 citations
Pulmonary vein isolation (PVI) is a well-established procedure for treating atrial fibrillation (AF); however, early recurrence of atrial tachyarrhythmias (ERAT) is common. Electrical cardioversion (ECV) is one treatment for ERAT, but optimal timing is unestablished.
To evaluate the association between the...
L. Serio, A. Askarinejad, T. Bucci et al.· European Heart Journal· 0 citations
Chronic kidney disease (CKD) is common in heart failure (HF) and is associated with adverse outcomes. However, its prognostic impact and the effects of contemporary HF therapies—including angiotensin receptor–neprilysin inhibitors (ARNI) and sodium–glucose cotransporter-2 inhibitors (SGLT2i)—on renal function rem...
E. Tartaglia, N. Bonini, M. Mantovani et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.